These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33067480)

  • 21. Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.
    Kmiecik J; Poli A; Brons NH; Waha A; Eide GE; Enger PØ; Zimmer J; Chekenya M
    J Neuroimmunol; 2013 Nov; 264(1-2):71-83. PubMed ID: 24045166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.
    Sayour EJ; McLendon P; McLendon R; De Leon G; Reynolds R; Kresak J; Sampson JH; Mitchell DA
    Cancer Immunol Immunother; 2015 Apr; 64(4):419-27. PubMed ID: 25555571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of immune cells within the tumor microenvironment of glioblastoma and their relevance for prognosis.
    Wang L; He Z; Fan S; Mo L; Li Y; Yuan X; Xu B; Mou Y; Yin Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113109. PubMed ID: 39255678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma.
    Yu M; Yu S; Zhou W; Yi B; Liu Y
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108293. PubMed ID: 34763232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local Targeting of NAD
    Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
    Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of immunobiologic markers in primary and recurrent glioblastoma.
    Rahman M; Kresak J; Yang C; Huang J; Hiser W; Kubilis P; Mitchell D
    J Neurooncol; 2018 Apr; 137(2):249-257. PubMed ID: 29302887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 28. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 29. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.
    Liao P; Han S; Qu H
    Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging- and Tumor-Mediated Increase in CD8
    Huff WX; Bam M; Shireman JM; Kwon JH; Song L; Newman S; Cohen-Gadol AA; Shapiro S; Jones T; Fulton K; Liu S; Tanaka H; Liu Y; Wan J; Dey M
    Immunohorizons; 2021 Jun; 5(6):395-409. PubMed ID: 34103370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.
    Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S
    Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hijacking Sexual Immuno-Privilege in GBM-An Immuno-Evasion Strategy.
    Sharpe MA; Baskin DS; Jenson AV; Baskin AM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 36. Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
    Luoto S; Hermelo I; Vuorinen EM; Hannus P; Kesseli J; Nykter M; Granberg KJ
    Cancer Res; 2018 Oct; 78(19):5574-5585. PubMed ID: 29921698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferating CD8
    Mauldin IS; Jo J; Wages NA; Yogendran LV; Mahmutovic A; Young SJ; Lopes MB; Slingluff CL; Erickson LD; Fadul CE
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy.
    Ji H; Ba Y; Ma S; Hou K; Mi S; Gao X; Jin J; Gong Q; Liu T; Wang F; Liu Z; Li S; Du J; Hu S
    Front Immunol; 2021; 12():729359. PubMed ID: 34566988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas.
    Wang Z; Yang X; Shen J; Xu J; Pan M; Liu J; Han S
    Hum Immunol; 2021 Apr; 82(4):279-287. PubMed ID: 33612391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.